Tag Archives: biotech

Week in DC: Additional insight into pharma/biotech industries

Our guest speaker from Breakaway Policy Strategies provided additional insight into the pharma/biotech industries and how drug costs, marketing efforts, and FDA activities are impacting the bio-pharma/med device landscape.  Some areas of interest included: Although prescription drug costs get a …